These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3486457)

  • 1. The fate of neonatally injected effector cells of allergic encephalomyelitis.
    Willenborg DO; Sjollema P; Danta G
    Scand J Immunol; 1986 Jan; 23(1):75-80. PubMed ID: 3486457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adoptive transfer of experimental allergic encephalomyelitis: recipient response to myelin basic protein-reactive lymphocytes.
    Bouwer HG; Hinrichs DJ
    J Neuroimmunol; 1994 Oct; 54(1-2):87-98. PubMed ID: 7523447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recipient contributions to serial passive transfer of experimental allergic encephalomyelitis.
    Wegmann KW; Hinrichs DJ
    J Immunol; 1984 May; 132(5):2417-23. PubMed ID: 6201543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfer of allergic encephalomyelitis with spleen cells from donors sensitized with myelin basic protein in incomplete Freund's adjuvant.
    Namikawa T; Richert JR; Driscoll BF; Kies MW; Alvord EC
    J Immunol; 1982 Feb; 128(2):932-4. PubMed ID: 6172517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune effector cells. III. Role of adjuvant and accessory cells in the in vitro induction of autoimmune encephalomyelitis.
    Killen JA; Swanborg RH
    J Immunol; 1982 Aug; 129(2):759-63. PubMed ID: 6177781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A myelin basic protein-specific T lymphocyte line that mediates experimental autoimmune encephalomyelitis.
    Vandenbark AA; Gill T; Offner H
    J Immunol; 1985 Jul; 135(1):223-8. PubMed ID: 2582032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of indomethacin treatment upon actively-induced and transferred experimental allergic encephalomyelitis (EAE) in Lewis rats.
    Ovadia H; Paterson PY
    Clin Exp Immunol; 1982 Aug; 49(2):386-92. PubMed ID: 6982136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune effector cells. IV. Induction of experimental allergic encephalomyelitis in Lewis rats without adjuvant.
    Holda JH; Silberg D; Swanborg RH
    J Immunol; 1983 Feb; 130(2):732-4. PubMed ID: 6184402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic relapsing experimental allergic encephalomyelitis in the Lewis rat: studies on immune regulation.
    Chow LH; Feurer C; Borel JF
    J Neuroimmunol; 1988 Oct; 19(4):329-38. PubMed ID: 3049665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of experimental allergic encephalomyelitis by transfer of lymph node cells from Lewis rats pretreated with complete Freund's adjuvant.
    Englert D; Hempel K
    Int Arch Allergy Appl Immunol; 1981; 66(3):326-31. PubMed ID: 6170593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of experimental allergic encephalomyelitis. III. Demonstration of effector cells in tolerant rats.
    Holda JH; Swanborg RH
    Eur J Immunol; 1981 Apr; 11(4):338-40. PubMed ID: 6166483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to experimental autoimmune encephalomyelitis induced by neonatal tolerization to myelin basic protein: clonal elimination vs. regulation of autoaggressive lymphocytes.
    Qin YF; Sun DM; Goto M; Meyermann R; Wekerle H
    Eur J Immunol; 1989 Feb; 19(2):373-80. PubMed ID: 2467819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of experimental allergic encephalomyelitis by MBP-coupled lymphoid cells and by MBP-liposomes: a comparison.
    Strejan GH; St Louis J
    Cell Immunol; 1990 May; 127(2):284-98. PubMed ID: 1691689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrathecal administration of antibodies against LFA-1 and against ICAM-1 suppresses experimental allergic encephalomyelitis in rats.
    Kawai K; Kobayashi Y; Shiratori M; Sobue G; Tamatani T; Miyasaka M; Yoshikai Y
    Cell Immunol; 1996 Aug; 171(2):262-8. PubMed ID: 8806796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoregulation of passively induced allergic encephalomyelitis.
    Willenborg DO; Sjollema P; Danta G
    J Immunol; 1986 Mar; 136(5):1676-9. PubMed ID: 2936807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppression of experimental allergic encephalomyelitis. III. In vitro evidence for induction of suppressor T lymphocytes in draining lymph node cells of animals immunized with myelin basic protein complexed to lipopolysaccharides.
    Raziuddin S; Kibler RF; Morrison DC
    J Immunol; 1982 May; 128(5):2073-80. PubMed ID: 6174621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune effector cells. I. Transfer of experimental encephalomyelitis with lymphoid cells cultured with antigen.
    Holda JH; Welch AM; Swanborg RH
    Eur J Immunol; 1980 Aug; 10(8):657-9. PubMed ID: 6967418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoregulation of experimental allergic encephalomyelitis: conditions for induction of suppressor cells and analysis of mechanism.
    Swierkosz JE; Swanborg RH
    J Immunol; 1977 Oct; 119(4):1501-6. PubMed ID: 70489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of effector cells in experimental allergic encephalomyelitis by interleukin 2 (IL-2).
    Ortiz-Ortiz L; Weigle WO
    J Immunol; 1982 Apr; 128(4):1545-50. PubMed ID: 6174605
    [No Abstract]   [Full Text] [Related]  

  • 20. Suppression of experimental allergic encephalomyelitis with thoracic duct lymphocytes.
    Frost H; Swanborg RH
    Int Arch Allergy Appl Immunol; 1980; 63(2):153-8. PubMed ID: 6158482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.